Authors:
BALLESTRERO A
CLAVIO M
FERRANDO F
SECONDO V
BASTA P
GONELLA R
GARUTI A
MIGLINO M
PIERRI I
CANEPA L
BELTRAMI G
VALLEBELLA E
GHIO R
GOBBI M
PATRONE F
Citation: A. Ballestrero et al., 3 STEP HIGH-DOSE CHEMOTHERAPY IN POOR-PROGNOSIS NON-HODGKIN-LYMPHOMA, Bone marrow transplantation, 21, 1998, pp. 613-613
Authors:
FERRANDO F
CLAVIO M
BALLESTRERO A
BALLERINI F
CAVALIERE M
BASTA P
GONELLA R
GARUTI A
MIGLINO M
PIERRI I
BELTRAMI G
GHIO R
GOBBI M
PATRONE F
Citation: F. Ferrando et al., HIGH-DOSE THERAPY WITH PBPC IN MM - A PRELIMINARY-REPORT OF GENOA EXPERIENCE, Bone marrow transplantation, 21, 1998, pp. 739-739
Authors:
BALLEARI E
BALLESTRERO A
BASON C
BASTA P
FERRANDO F
GARRE S
GARUTI A
MASSA G
RICHERO P
PATRONE F
GHIO R
Citation: E. Balleari et al., EXPANSION OF PURIFIED CIRCULATING CD34-DOSE CHEMOTHERAPY( HEMATOPOIETIC PROGENITOR CELLS (HPC) AS POSSIBLE SUPPORT FOR HIGH), Bone marrow transplantation, 21, 1998, pp. 829-829
Authors:
SESSAREGO M
FUGAZZA G
GOBBI M
BRUZZONE R
BISIO R
GHIO R
PATRONE F
Citation: M. Sessarego et al., COMPLEX STRUCTURAL INVOLVEMENT OF CHROMOSOME-7 IN PRIMARY MYELODYSPLASTIC SYNDROMES DETERMINED BY FLUORESCENCE IN-SITU HYBRIDIZATION, Cancer genetics and cytogenetics, 106(2), 1998, pp. 110-115
Authors:
BALLESTRERO A
FERRANDO F
STURA P
PUGLISI M
BREMA F
PATRONE F
Citation: A. Ballestrero et al., STANDARD-DOSE RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR(RHG-CSF) ALLOWS SAFE AND REPEATED ADMINISTRATION OF HIGH-DOSE CYCLOPHOSPHAMIDE, ETOPOSIDE, AND CISPLATIN (CEP), American journal of clinical oncology, 20(3), 1997, pp. 266-271
Authors:
SESSAREGO M
FUGAZZA G
BALLEARI E
BRUZZONE R
BALLESTRERO A
PATRONE F
Citation: M. Sessarego et al., HIGH-FREQUENCY OF TRISOMY-8 IN ACUTE PROMYELOCYTIC LEUKEMIA - A FLUORESCENCE IN-SITU HYBRIDIZATION STUDY, Cancer genetics and cytogenetics, 97(2), 1997, pp. 161-164
Authors:
FUGAZZA G
BRUZZONE R
PUPPO L
PATRONE F
SESSAREGO M
Citation: G. Fugazza et al., AMPLIFIED C-MYC SEQUENCES LOCALIZED BY FLUORESCENCE IN-SITU HYBRIDIZATION ON DOUBLE MINUTE CHROMOSOMES IN ACUTE MYELOID LEUKEMIAS, Leukemia research, 21(8), 1997, pp. 703-709
Authors:
BALLESTRERO A
FERRANDO F
GARUTI A
BASTA P
GONELLA R
ESPOSITO M
VANNOZZI MO
SORICE G
FRIEDMAN D
PUGLISI M
BREMA F
MELA GS
SESSAREGO M
PATRONE F
Citation: A. Ballestrero et al., HIGH-DOSE MITOXANTRONE WITH PERIPHERAL-BLOOD PROGENITOR-CELL RESCUE -TOXICITY, PHARMACOKINETICS AND IMPLICATIONS FOR DOSAGE AND SCHEDULE, British Journal of Cancer, 76(6), 1997, pp. 797-804
Authors:
CLAVIO M
CARRARA P
MIGLINO M
PIERRI I
CANEPA L
BALLEARI E
GATTI AM
CERRI R
CELESTI L
VALLEBELLA E
SESSAREGO M
PATRONE F
GHIO R
DAMASIO E
GOBBI M
Citation: M. Clavio et al., HIGH EFFICACY OF FLUDARABINE-CONTAINING THERAPY (FLAG-FLANG) IN POOR-RISK ACUTE MYELOID-LEUKEMIA, Haematologica, 81(6), 1996, pp. 513-520
Authors:
BREMA F
PATRONE F
AMOROSO D
BALLESTRERO A
DESANCTIS C
FERRANDO F
FOLCO U
IRTELLI L
MAMMOLITI S
MESITI M
PACINI P
RINALDINI M
VENTURINI M
BOCCARDO F
Citation: F. Brema et al., ADJUVANT HIGH-DOSE CHEMOTHERAPY (HD CT) WITHOUT BONE-MARROW RESCUE INBREAST-CANCER PATIENTS (BC PTS) WITH 10 OR MORE POSITIVE AXILLARY NODES (N-GREATER-THAN-OR-EQUAL-TO-10) - PRELIMINARY FINDINGS FROM A GROCTA PILOT-STUDY, European journal of cancer, 31A, 1995, pp. 49-49
Authors:
FUGAZZA G
BRUZZONE R
DEJANA AM
GOBBI M
GHIO R
PATRONE F
RATTENNI S
SESSAREGO M
Citation: G. Fugazza et al., CYTOGENETIC CLONALITY IN CHRONIC MYELOMONOCYTIC LEUKEMIA STUDIED WITHFLUORESCENCE IN-SITU HYBRIDIZATION, Leukemia, 9(1), 1995, pp. 109-114
Authors:
PATRONE F
BALLESTRERO A
FERRANDO F
BREMA F
MORAGLIO L
VALBONESI M
BASTA P
GHIO R
GOBBI M
SESSAREGO M
Citation: F. Patrone et al., 4-STEP HIGH-DOSE SEQUENTIAL CHEMOTHERAPY WITH DOUBLE HEMATOPOIETIC PROGENITOR-CELL RESCUE FOR METASTATIC BREAST-CANCER, Journal of clinical oncology, 13(4), 1995, pp. 840-846
Authors:
SESSAREGO M
FUGAZZA G
CANEPA L
BACIGALUPO A
BRUZZONE R
PATRONE F
Citation: M. Sessarego et al., FLUORESCENCE IN-SITU HYBRIDIZATION PROVIDES EVIDENCE FOR 2-STEP REARRANGEMENT IN A MASKED PH CHROMOSOME FORMATION, Leukemia research, 19(12), 1995, pp. 921-925
Authors:
CLAVIO M
CARRARA P
SPRIANO M
PIERRI I
CANEPA L
MIGLINO M
CELESTI L
ROSSI E
GHIO R
PATRONE F
DAMASIO E
GOBBI M
Citation: M. Clavio et al., FLUDARABINE THERAPY IN IMMUNOCYTOMA AND OTHER LOW-GRADE NON-HODGKINS-LYMPHOMAS, Journal of experimental & clinical cancer research, 13(3), 1994, pp. 257-263
Authors:
CLAVIO M
CARRARA P
SPRIANO M
PIERRI I
CANEPA L
MIGLINO M
CELESTI L
ROSSI E
GHIO R
PATRONE F
DAMASIO E
GOBBI M
Citation: M. Clavio et al., FLUDARABINE THERAPY IN IMMUNOCYTOMA AND OTHER LOW-GRADE NON-HODGKINS-LYMPHOMAS, Journal of experimental & clinical cancer research, 13(3), 1994, pp. 257-263
Authors:
SPRIANO M
CLAVIO M
CARRARA P
CANEPA L
MIGLINO M
PIERRI I
CELESTI L
ROSSI E
VIMERCATI R
BRUNI R
SANTINI G
GATTI AM
STURA P
GHIO R
PATRONE F
DAMASIO E
GOBBI M
Citation: M. Spriano et al., FLUDARABINE IN UNTREATED AND PREVIOUSLY TREATED B-CLL PATIENTS - A REPORT ON EFFICIENCY AND TOXICITY, Haematologica, 79(3), 1994, pp. 218-224
Authors:
SESSAREGO M
FUGAZZA G
BRUZZONE R
PATRONE F
Citation: M. Sessarego et al., VARIANT PHILADELPHIA-CHROMOSOME TRANSLOCATIONS ARE FREQUENTLY ASSOCIATED WITH ADDITIONAL STRUCTURAL ABNORMALITIES, Cancer genetics and cytogenetics, 73(1), 1994, pp. 57-59
Authors:
FUGAZZA G
BRUZZONE R
DEJANA AM
PATRONE F
SESSAREGO M
Citation: G. Fugazza et al., TRISOMY 8 DETECTION IN PH(-SITU HYBRIDIZATION TECHNIQUES() CML PATIENTS USING CONVENTIONAL CYTOGENETIC AND INTERPHASE FLUORESCENCE IN), Cancer genetics and cytogenetics, 72(1), 1994, pp. 24-27
Authors:
GHIO R
BALLEARI E
BALLESTRERO A
GATTI AM
MARENI C
MASSA G
PATRONE F
SESSAREGO M
TIMITILLI S
Citation: R. Ghio et al., SUBCUTANEOUS RECOMBINANT-HUMAN-ERYTHROPOIETIN FOR THE TREATMENT OF ANEMIA IN MYELODYSPLASTIC SYNDROMES, Acta haematologica, 90(2), 1993, pp. 58-64